Recent Highlights
All Stories for Astrazeneca
Serum Institute pledges over $66 million to Oxford University for vaccine research centre
Fp Staff • 3 years agoThe main focus of the research taking place in the Poonawalla Building will be vaccinology and it will house over 300 research scientists
WHO pushes back decision on Covaxin's EUL again, seeks more data
• 4 years agoThe UN health body said that the TAG expects to reconvene for the final risk-benefit assessment on 3 November
Tedros Adhanom, Mansukh Mandaviya discuss emergency use listing of Covaxin on phone call
• 4 years agoThe WHO director general said he also discussed vaccine equity issues, resumption of SII/AstraZeneca vaccine supplies, Covaxin EUL process and technology and license sharing through C-TAP
WHO chief and Health Minister discuss Covaxin's EUL, vaccine equity and supplying COVAX during virtual call
• 4 years agoIndia will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the Vaccine Maitri' programme and to meet its commitment to the COVAX global pool.
AstraZeneca's COVID antibody drug shows reduction in severe infection, death in its phase 3 trials
• 4 years agoThe treatment - AZD7442 - is made from a combination of two antibodies and was given to 903 participants with 90 percent of them having a high risk of progression to severe COVID-19.
COVID vaccines effective at preventing severe infection, 90 percent less likely to be hospitalised or die finds study
• 4 years agoThis study is one of the largest research conducted with them looking at data from 22 million people over 50 years starting in December 2020.
AstraZeneca seeks FDA's emergency use approval for its COVID-19 antibody treatment drug
• 4 years agoLate-stage human trials showed that AstraZeneca’s antibody drug reduced the risk of developing symptomatic COVID-19 by 77 percent.
COVID-19 vaccine certificate controversy: Britain can antagonise India at its own peril
Sandipghose • 4 years agoIndia needs to be an equal partner on a host of other responses – not the least among them is our Co-Win software. In this situation, Britain can antagonise India at its own peril. And the ramifications of it will not be restricted to the Covid response alone.
COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
• 4 years agoOxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant
How does the COVID-19 vaccine work once it enters the body – Roadmap for kids and adults
• 4 years agoAs soon as the vaccine is inside the tissue cells, it uses the instructions to create spike proteins. This process usually takes less than 12 hours.